Serum adipokine (apelin) in lean and obese polycystic ovary syndrome patients before and after metformin treatment

被引：5
|
作者：
Hasan, Mai M. [1 ]
Abd El Hameed, Azza A. [2 ]
机构：
[1] Zagazig Univ, Fac Med, Dept Physiol, Zagazig, Egypt
[2] Zagazig Univ, Fac Med, Dept Obstet & Gynaecol, Zagazig, Egypt
来源：
MIDDLE EAST FERTILITY SOCIETY JOURNAL | 2018年 / 23卷 / 04期
关键词：
D O I：
10.1016/j.mefs.2018.04.003
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：315 / 318
页数：4
相关论文
共 50 条
  • [31] Transient decrease in serum leptin during metformin therapy in obese women with polycystic ovary syndrome
    Morin-Papunen, L
    Koivunen, R
    Ruokonen, A
    Martikainen, H
    HUMAN REPRODUCTION, 1998, 13 : 253 - 253
  • [32] Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
    Zhao, Ting
    Xiao, Xiao
    Li, Lingchuan
    Zhu, Jing
    He, Wenli
    Zhang, Qiong
    Wu, Jiaqi
    Wu, Xiaomei
    Yuan, Tao
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [33] Metformin before and during pregnancy and lactation in polycystic ovary syndrome
    Glueck, Charles J.
    Wang, Ping
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (02) : 191 - 198
  • [34] Frequency of Non-Obese Women with Polycystic Ovary Syndrome and Efficacy of Metformin in Non-Obese Women with Polycystic Ovary Syndrome
    Qadir, Sara
    Aslam, Tauqeer
    Rabbani, Maryam
    Malik, Sajid
    Rabbani, Amna
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (03): : 898 - 899
  • [35] Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
    Raperport, Claudia
    Chronopoulou, Elpiniki
    Homburg, Roy
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2021, 16 (02) : 37 - 47
  • [36] Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance
    Song, Jinghua
    Ruan, Xiangyan
    Gu, Muqing
    Wang, Lijuan
    Wang, Husheng
    Mueck, Alfred Otto
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (05) : 413 - 417
  • [37] Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study
    Mancini, Fulvia
    Cianciosi, Arianna
    Persico, Nicola
    Facchinetti, Fabio
    Busacchi, Paolo
    Battaglia, Cesare
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (02) : 169.e1 - 169.e8
  • [38] The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome
    Akin Usta
    Eyup Avci
    Cagla Bahar Bulbul
    Hasan Kadi
    Ertan Adali
    Reproductive Biology and Endocrinology, 16
  • [39] The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome
    Usta, Akin
    Avci, Eyup
    Bulbul, Cagla Bahar
    Kadi, Hasan
    Adali, Ertan
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2018, 16
  • [40] The Effects of Rosiglitazone, Metformin, and Estradiol-Cyproterone Acetate on Lean Patients With Polycystic Ovary Syndrome
    Cetinkalp, Sevki
    Karadeniz, Muammer
    Erdogan, Mehmet
    Ozgen, Gokhan
    Saygili, Fuesun
    Yilmaz, Candeger
    ENDOCRINOLOGIST, 2009, 19 (03): : 94 - 97
12345